The guideline on the screen. The decision with your tumour board.
In OncoSync's breast cancer pathways a recommendation arrives with the reference behind it, so the panel can see what the suggestion rests on before it agrees or departs from it.
Guideline-referenced, not guideline-certified. OncoSync holds no certification from NCCN or any guideline body, and a recommendation is not an approval — the treating clinician decides.